- Home
- WELL vs MDT Comparison
WELL vs MDT Comparison
Compare WELL & MDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WELL | MDT |
|---|---|---|
| Founded | 1970 | 1949 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 136.6B | 131.9B |
| IPO Year | 1994 | 2014 |
Fundamental Metrics
Financial Performance| Metric | WELL | MDT |
|---|---|---|
| Price | $210.31 | $83.33 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 21 |
| Target Price | ★ $224.38 | $108.21 |
| AVG Volume (30 Days) | 2.1M | ★ 7.4M |
| Earning Date | 04-28-2026 | 06-03-2026 |
| Dividend Yield | 1.42% | ★ 3.41% |
| EPS Growth | N/A | ★ 30.80 |
| EPS | 1.39 | ★ 2.76 |
| Revenue | $10,838,034,000.00 | ★ $33,537,000,000.00 |
| Revenue This Year | $23.20 | $8.91 |
| Revenue Next Year | $11.62 | $6.54 |
| P/E Ratio | $150.71 | ★ $30.21 |
| Revenue Growth | ★ 35.63 | 3.62 |
| 52 Week Low | $142.65 | $79.93 |
| 52 Week High | $216.43 | $106.33 |
Technical Indicators
Market Signals| Indicator | WELL | MDT |
|---|---|---|
| Relative Strength Index (RSI) | 56.85 | 35.58 |
| Support Level | $182.12 | N/A |
| Resistance Level | $215.32 | $89.01 |
| Average True Range (ATR) | 4.97 | 1.64 |
| MACD | 0.17 | -0.11 |
| Stochastic Oscillator | 71.51 | 18.82 |
Price Performance
Historical ComparisonAbout WELL Welltower Inc.
Welltower owns a diversified healthcare portfolio of 2,900 in-place properties spread across the senior housing, medical office, and skilled nursing/postacute care sectors. The portfolio includes over 900 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to that of the United States.
About MDT Medtronic plc.
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.